Education
About Us
Working with TipRanks
Follow Us
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
2X-121 And Dovitinib
Advanced Solid Tumors
Phase I
Suspended
Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors
Oct 05, 2022
―
Ixabepilone Injection
Metastatic Breast Cancer
Phase II
Suspended
Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.
Mar 08, 2021
―
2X-121
Advanced Ovarian Cancer
Phase II
Recruiting
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
Mar 08, 2019
―
Irofulven, Prednisolone 10 Mg
Metastatic Castration-Resistant Prostate Cancer Patients
Phase II
Completed
Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)
Aug 21, 2018
―
Parp Inhibitor 2X-121
Metastatic Breast Cancer
Phase II
Completed
Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP
Apr 26, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Allarity Therapeutics, Inc. (ALLR) have in its pipeline
ALLR is currently developing the following drugs: 2X-121 And Dovitinib, Ixabepilone Injection, 2X-121. These drug candidates are in various stages of clinical development as the company works toward FDA approval.